Brief: Reviva Pharmaceuticals Holdings Inc - Enters Into At Market Issuance Sales Agreement - SEC Filing
30/05/2025 21:15
May 30 (Reuters) - Reviva Pharmaceuticals Holdings Inc RVPH.O: REVIVA PHARMACEUTICALS HOLDINGS INC - ENTERS INTO AT MARKET ISSUANCE SALES AGREEMENT - SEC FILING REVIVA PHARMACEUTICALS HOLDINGS INC - TO OFFER UP TO $50 MILLION IN COMMON STOCK - SEC FILING Source text: [ID:n0001437749-25-018972] Further company coverage: RVPH.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Reviva Pharmaceuticals Holdings
See all newsReviva Pharmaceuticals Q1 net loss narrows on lower expenses
Brief: Reviva Pharmaceuticals Holdings Inc - To Be Delisted From Nasdaq Trading Suspended As Of May 14, 2026 - SEC Filing
Brief: Reviva Reports Full Year 2025 Financial Results And Recent Business Highlights
Reviva Pharmaceuticals' 2025 net loss narrows on lower R&D spending
U.S. STOCKS ON THE MOVE-Darden Restaurants, Mastercard, Accenture